Babay Pharma
ActiveSummary
The computed 12-month bankruptcy probability of Babay Pharma is 4.2% (elevated). The 2024 annual accounts show equity of €31,917 and a net result of €1,917. Its solvency ranks better than 38% of 26040 sector peers (fiscal year 2024). The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
This company filed its 2024 accounts 22 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 46% of the sector filed late.
Checked, nothing found (1)
History
Go further with this company
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, micro schema
Turnover and EBIT margin not published: the micro schema does not require them.
Peer companies
Historical observationOf the 2,541 companies that looked in July 2024 the way this one looks now, 3.3% went bankrupt within 24 months and 95% are still going.
- Micro
- 2 to 5 years old
- solvency 10 to 30%
- a profit under 5% of the balance sheet
A further 0.7% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a higher bankruptcy probability: 4.2% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.6% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 2,541 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2024 |
|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €9,953 |
| Other operating charges640/8 | €228 |
| Gross operating margin9900 | €15,027 |
| Operating profit (loss)9901 | €4,845 |
| Financial income75/76B | €0 |
| Recurring financial income75 | €0 |
| Financial charges65/66B | €2,290 |
| Recurring financial charges65 | €2,290 |
| Profit (loss) for the period before taxes9903 | €2,556 |
| Income taxes67/77 | €639 |
| Profit (loss) for the period9904 | €1,917 |
| Profit (loss) for the period to be appropriated9905 | €1,917 |
| Line | 2024 | |
|---|---|---|
| Assets | ||
| Total assets20/58 | €169,708 | |
| Fixed assets21/28 | €142,869 | |
| Intangible fixed assets21 | €142,869 | |
| Current assets29/58 | €26,839 | |
| Amounts receivable within one year40/41 | €21,799 | |
| Trade receivables40 | €15,958 | |
| Other amounts receivable41 | €5,841 | |
| Cash at bank and in hand54/58 | €5,040 | |
| Equity and liabilities | ||
| Total equity and liabilities10/49 | €169,708 | |
| Equity10/15 | €31,917 | |
| Contributions10/11 | €30,000 | |
| Profit (loss) carried forward14 | €1,917 | |
| Amounts payable17/49 | €137,791 | |
| Amounts payable after more than one year17 | €80,605 | |
| Financial debts170/4 | €80,605 | |
| Amounts payable within one year42/48 | €57,186 | |
| Current portion of amounts payable after more than one year42 | €18,895 | |
| Trade debts44 | €28,688 | |
| Suppliers440/4 | €28,688 | |
| Taxes, remuneration and social security45 | €6,014 | |
| Taxes450/3 | €6,014 | |
| Other amounts payable47/48 | €3,589 | |
| Line | 2024 |
|---|---|
| Profit (loss) for the period9904 | €1,917 |
| + Depreciation and write-downs630 | €9,953 |
| Operating cash flow (approximation) | €11,870 |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Directors · office · real estate
1 establishment unit
2 parcels
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21572B0012/00S005 | Brussels | 118 m² | 1 · 73 m² | 14.9 m · 4 fl. |
| 21572B0011/00L000 | Brussels | 51 m² | 1 · 49 m² | 15.6 m · 4 fl. |
Linked by address, not proof of ownership
Similar companies · same sector, comparable size
Identification & contact
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.